Christopher Charles Karayiannis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Christopher Charles Karayiannis has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Thanh G. Phan
Monash University
3 shared publications - Alexandros A. Polymeris
Department of Neurology and Stroke Center, Department of Clinical Research, University Hospital Basel and University of Basel , Basel
2 shared publications - Annaelle Zietz
Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Basel, Switzerland 1
2 shared publications - Benjamin Wagner
Department of Neurology and Stroke Center, University Hospital Basel and University of Basel, Basel, Switzerland
2 shared publications - Cyrus Cheng
Division of Neurology, Department of Medicine, The University of Hong Kong
2 shared publications - Daniel Bos
Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands
2 shared publications
Latest Publications
- 10 November 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (9) , e218755
Association of Enlarged Perivascular Spaces and Total Small Vessel Disease Burden With Kidney Function
- 10 November 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (9) , e218755
Association of Enlarged Perivascular Spaces and Total Small Vessel Disease Burden With Kidney Function
- Open Access
- 25 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (4) , e218406
Association of Enlarged Perivascular Spaces and Total Small Vessel Disease Burden With Kidney Function
Background and ObjectivesEnlarged perivascular spaces (EPVSs) in the basal ganglia (BG-EPVS) are an important marker of cerebral small vessel disease (cSVD), and EPVS in the centrum semiovale (CSO-...
- 25 August 2026
- Published by Wolters Kluwer Health in Neurology
- Vol. 107 (4) , e218406
Open AccessAssociation of Enlarged Perivascular Spaces and Total Small Vessel Disease Burden With Kidney Function
Background and ObjectivesEnlarged perivascular spaces (EPVSs) in the basal ganglia (BG-EPVS) are an important marker of cerebral small vessel disease (cSVD), and EPVS in the centrum semiovale (CSO-...
- Open Access
- 3 November 2022
- Published by Wiley in Internal Medicine Journal
- Vol. 52 (11) , 1877-1883
Hypertension in the older person: is age just a number?
Older patients with hypertension are at a higher risk of cardiovascular events compared to younger adults but are also more vulnerable to the adverse effects of blood pressure (BP) lowering. Frailty is an important predictor of vulnerability to such adverse events, and age alone may not best reflect underlying risk. Therefore, an individualised approach to management of hypertension in the older person is required. Such an approach requires knowledge of frailty, the physiology of hypertension and ageing and a contextual understanding of best evidence. Management needs to be holistic and take account of the older person's care needs, wishes and priorities. This review describes physiological considerations and current guidelines and best practices regarding BP lowering in older people and highlights areas with paucity of evidence. A proposed and testable approach to managing hypertension in the older person (>= 70 years) is discussed.
- 3 November 2022
- Published by Wiley in Internal Medicine Journal
- Vol. 52 (11) , 1877-1883
Open AccessHypertension in the older person: is age just a number?
Older patients with hypertension are at a higher risk of cardiovascular events compared to younger adults but are also more vulnerable to the adverse effects of blood pressure (BP) lowering. Frailty is an important predictor of vulnerability to such adverse events, and age alone may not best reflect underlying risk. Therefore, an individualised approach to management of hypertension in the older person is required. Such an approach requires knowledge of frailty, the physiology of hypertension and ageing and a contextual understanding of best evidence. Management needs to be holistic and take account of the older person's care needs, wishes and priorities. This review describes physiological considerations and current guidelines and best practices regarding BP lowering in older people and highlights areas with paucity of evidence. A proposed and testable approach to managing hypertension in the older person (>= 70 years) is discussed.
- Open Access
- 21 December 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (24) , e022240
Is Blood Pressure Lowering in the Very Elderly With Previous Stroke Associated With a Higher Risk of Adverse Events?
Background: We investigated whether blood pressure lowering for secondary prevention is associated with a reduction in recurrent stroke risk and/or a higher risk of adverse events in very elderly compared with younger trial participants. Methods and Results: This is a random effects meta‐analysis of randomized controlled trials of blood pressure lowering for secondary stroke prevention to evaluate age‐stratified (2 =49%), and the magnitude of risk reduction did not differ by age subgroup (2 =0%), but there was an increased risk in those ≥80 years (RR, 2.17 [95% CI, 1.22], 3.86, I 2 =0%). No increase was observed in the risk of falls, syncope, study withdrawal, or falls in either age subgroup. Conclusions: Very elderly people in secondary prevention trials of blood pressure lowering have an increased risk of hypotensive symptoms, but with no statistical increase in the risk of falls, syncope, or mortality. However, evidence is lacking for frail elderly with multiple comorbidities who may be more vulnerable to adverse effects of blood pressure lowering.
- 21 December 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (24) , e022240
Open AccessIs Blood Pressure Lowering in the Very Elderly With Previous Stroke Associated With a Higher Risk of Adverse Events?
Background: We investigated whether blood pressure lowering for secondary prevention is associated with a reduction in recurrent stroke risk and/or a higher risk of adverse events in very elderly compared with younger trial participants. Methods and Results: This is a random effects meta‐analysis of randomized controlled trials of blood pressure lowering for secondary stroke prevention to evaluate age‐stratified (2 =49%), and the magnitude of risk reduction did not differ by age subgroup (2 =0%), but there was an increased risk in those ≥80 years (RR, 2.17 [95% CI, 1.22], 3.86, I 2 =0%). No increase was observed in the risk of falls, syncope, study withdrawal, or falls in either age subgroup. Conclusions: Very elderly people in secondary prevention trials of blood pressure lowering have an increased risk of hypotensive symptoms, but with no statistical increase in the risk of falls, syncope, or mortality. However, evidence is lacking for frail elderly with multiple comorbidities who may be more vulnerable to adverse effects of blood pressure lowering.